亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢楷倫公司銷售部  

埃索美拉唑,埃索美拉唑鎂三水合物,5-甲氧基-2-巰基-1H-苯并咪唑,頭孢雷特,普格拉雷等

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:童瑤
  • 電話:027-88395717
  • 郵件:kailun002@126.com
  • 傳真:027-88735683
  • QQ:2524490512
站內搜索
 
榮譽資質
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 190595-65-4依替米貝中間體的廠家
190595-65-4依替米貝中間體的廠家
單價 1111.00 / kg對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 11kg起訂1kg
品牌 190595-65-4
型號 190595-65-4
規格 190595-65-4
過期 長期有效
更新 2013-09-26 11:10
 
詳細信息
  (3R,4S)-1-(4-氟苯)-3-[3-(4-氟苯-3-氧基丙基]-4-[4-(苯甲氧基)苯基], 2-氮雜環丁酮  
英文名: 190595-65-4依替米貝中間體的廠家
1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(phenylmethoxy)phenyl]-, (3R,4S)- 2-azetidinone
 CAS No.:190595-65-4
英文名稱: (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one 
中文名稱: (3R,4S)-4-[4-(芐氧基)苯基]-1-(4-氟苯基)-3-[3-(4-氟苯基)-3-氧代丙基]氮雜環丁烷-2-酮 
MF: C31H25F2NO3 
MW: 497.53 
CAS: 190595-65-4 
結構式:190595-65-4是依替米貝中間體

  (3R,4S)-1-(4-氟苯)-3-[3-(4-氟苯-3-氧基丙基]-4-[4-(苯甲氧基)苯基], 2-氮雜環丁酮  
英文名: 190595-65-4依替米貝中間體的廠家
1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(phenylmethoxy)phenyl]-, (3R,4S)- 2-azetidinone
 CAS No.:190595-65-4
英文名稱: (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one 
中文名稱: (3R,4S)-4-[4-(芐氧基)苯基]-1-(4-氟苯基)-3-[3-(4-氟苯基)-3-氧代丙基]氮雜環丁烷-2-酮 
MF: C31H25F2NO3 
MW: 497.53 
CAS: 190595-65-4 
結構式:190595-65-4是依替米貝中間體


©2025 武漢楷倫公司銷售部 版權所有   技術支持:化工網   訪問量:10696  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |